Found 14 matching trials
Evaluating a Shorter, Rifampicin-Based Treatment for People With Less Severe Tuberculosis Disease
PHASE3RIFAstrat is a Phase 3, double-blind, placebo-controlled, non-inferiority t...
Location
Multiple Locations
Fermented Soybean Supplementation Among Active Pulmonary Tuberculosis Patients With Standard Therapy in Indonesia
NATuberculosis (TB) patients often have a lower body mass index (BMI) and exp...
Location
Multiple Locations
Determination of Adequate Tuberculosis Regimen in Patients Hospitalized With HIV-associated Severe Immune Suppression
PHASE3DATURA trial is a phase III, multicenter, two-arm, open-label, randomized s...
Location
National Center for HIV/AIDS, Dermatology and STD (NCHADS)
Essentiality of INH in TB Therapy
PHASE2Tuberculosis (TB) disease is caused by bacteria that have infected the lung...
Location
University of Cape Town Lung Institute (UCTLI) CRS (31792)
Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST Study
PHASE2The purpose of this study was to compare a 3-month rifapentine (RPT)/clofaz...
Location
Les Centres GHESKIO Clinical Research Site (GHESKIO-INLR) CRS
PNU-100480 In Newly Diagnosed, Drug Sensitive Patients With Pulmonary TB; Early Bactericidal Activity; Whole Blood Assay
PHASE2PNU-100480 is being developed for the treatment of both drug resistant and ...
Location
Pfizer Investigational Site
B-PaLMZ for TB Meningitis
PHASE2This two-stage study will compare consented research participants with tube...
Location
Infectious Diseases Institute
Azacytidine During Anti-tuberculosis Therapy
PHASE1Tuberculosis has been shown to make immune genes inaccessible and slows imm...
Location
Harris Health System - Ben Taub Hospital
Latency in Pulmonary Tuberculosis
PHASE3The immune responses in latent tuberculosis are poorly understood. While it...
Location
Tuberculosis Research Centre
A Phase 2 Study to Evaluate Early Bactericidal Activity, Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of Telacebec (Q203)
PHASE2This is a Phase IIa, open-label, randomized study in treatment-naïve, sputu...
Location
TASK Applied Science